Newsletter | June 1, 2020

06.01.20 -- The (Almost) Insurmountable Recruitment Challenges Of Antibiotic Clinical Trials

Featured Editorial
Industry Insights
COVID-19 FDA Response: Guidance On Protocol Amendments And Clinical Study Reports In Affected Ongoing Trials

One of the impacts of the COVID-19 pandemic on the conduct of ongoing and planned clinical trials will be the need for protocol modifications to adjust for COVID-19 control measures and COVID-19 illness. This blog reviews recent FDA guidance that offers advice on managing protocol amendments and deviations and documenting changes to the trial.

Lumenis: Reducing Site Workload For Better, Faster, Safer Clinical Trials

Life sciences companies are under increasing pressure to execute clinical trials faster with higher quality. Read survey results that show that as the Lumenis platform adoption increased, study teams began to see an improvement in data quality, operational efficiency, and ease of use compared to traditional paper and electronic data capture (EDC) methods.

Receiving Finished Pharmaceuticals At The Repository

The value of your work lies in the integrity of your materials. Ensuring pharmaceutical agents are handled properly and maintained at the correct temperature throughout all processes is imperative to maximal long-term viability and usability. This means not only during the processing and preparation of finished pharmaceuticals for storage — it also means during the transportation process. Have you ever wondered how finished pharmaceuticals travel through the repository? This infographic will provide you with an end-to-end overview of the process, from the initial agent receipt to the final release.

New Opportunities And Implications For The Future Of Drug Development In Emerging Economies

Ed Mills, Cytel’s vice president of real-world evidence, hosts a panel on how COVID-19 is affecting access to drug development and equitable medical care in emerging economies.


June 4, 2020 | 11:00 AM EDT


We're here to help during this challenging time.

Effectively sourcing and contracting service providers is uniquely difficult this year. But, choosing the right partner is no less critical. Clinical Leader’s new Sourcing Centers enable you to quickly browse the services and capabilities of a diverse group of suppliers who can help with your unique clinical research and trial needs. Our Sourcing Centers include:

Phase I-III CRO Services | Phase IV CRO Services
Clinical Trial Software and Services | Patient & Site Services